Cape Coast Hepatitis B and C Screening and treatment eligibility assessment dataset

Published: 1 May 2024| Version 1 | DOI: 10.17632/4d6xynfdsy.1
Contributor:
Oheneba C K Hagan

Description

Accessibility to treatment for individuals infected with hepatitis B and C remain poor in LMICs including Ghana. Poor rate of diagnosis and assessment for treatment remain the 2 most important factors attributable to this problem. Improving the screening rate and making the treatment eligibility assessment affordable will improve the accessibility to treatment. The study site was at a primary health care facility where regular screening is undertaken for walk-ins and the referred. The dataset are 2, comprising the screened the data from retrospective review of records and a cross-sectional study of treatment eligibility assessment for those diagnosed with hepatitis B. Genotyping was also undertaken and the chromatograph of the Sanger sequencing has also been added here

Files

Institutions

  • Korle Bu Teaching Hospital
  • University of Cape Coast

Categories

Viral Hepatitis, Hepatitis B, Hepatitis C

Funders

  • University of Cape Coast Directorate of Research, Innovation and Consultancy

Licence